microdose glp 1 vs full dose GLP-1 Microdosing and Custom Dosing Standard Dose vs Microdose GLP-1:

The transition protocol from tirzepatide provides specific guidance for this switch

Going back to the STEP-UP trial with semaglutide it was seen in about 20% of patients in that trial as well on the 7.2mg dose

(Nutrients, 2018) - a 12-month, randomized, double-blinded, placebo-controlled study of 131 postmenopausal women with reduced bone density

Retatrutide is still investigational

Tirzepatide dosing protocol Tirzepatide follows a well-established escalation schedule refined through multiple clinical trials and years of real-world use: Weeks 1-4: 2.5 mg once weekly (starting dose) Weeks 5-8: 5 mg once weekly Weeks 9-12: 7.5 mg once weekly (optional intermediate step) Weeks 13-16: 10 mg once weekly Weeks 17-20: 12.5 mg once weekly (optional intermediate step) Week 21+: 15 mg once weekly (maximum dose) The starting dose of 2.5 mg is intentionally subtherapeutic

Each session usually takes less than an hour